Director, BD Early Stage — CSL Behring
- Lieu
- Bern
- Contrat
- full-time
- Publié
- Hier
Vue d’ensemble du poste
The Director, BD Early Stage leads the assessment of earl y- stage external innovation opportunities from Due Diligence Stage 2 to negotiation of a Non-Binding Offer ( NBO ) .
The role integrates evolving scientific advances, therapeutic trends and market dynamics to guide CSL's long-range BD investment decisions in early - stage opportunities.
It provides deep subject-matter leadership and enterprise-level judgement to ensure potential partnerships and acquisitions advance CSL’s portfolio impact, scientific differentiation and competitive positioning.
- The Director, BD Early Stage leads the assessment of earl y- stage external innovation opportunities from Due Diligence Stage 2 to negotiation of a Non-Binding Offer ( NBO ) .
- The role integrates evolving scientific advances, therapeutic trends and market dynamics to guide CSL's long-range BD investment decisions in early - stage opportunities.
- & Accountabilities External Innovation Evaluation Leadership:
- Lead evaluation of early-stage external assets, technologies, platforms and modalities aligned to TA Strategy from Due Diligence Stage 2 through Governance to negotiation of NBO.
- CSL’s evaluation standards and prioritization frameworks to ensure rigor, consistency and balanced risk-benefit assessment.
Responsabilités principales
- & Accountabilities External Innovation Evaluation Leadership:
- Lead evaluation of early-stage external assets, technologies, platforms and modalities aligned to TA Strategy from Due Diligence Stage 2 through Governance to negotiation of NBO.
- Integrate scientific, clinical, mechanistic, regulatory and commercial evidence into holistic assessments of attractiveness, differentiation and enterprise and TA strategic fit.
- Development of Investment-Ready Assessments:
- Deliver investment-quality inputs such as valuation assumptions, scenario modelling, unmet need assessments, deal analogues and downstream implications (e.g., biomarker requirements, specialized development pathways, manufacturing needs).
- Translate complex scientific and clinical narratives into clear, concise and decision-ready recommendations for CSL senior leaders.
- Strategic Judgement and Opportunity Prioritization:
- Provide recommendations on progressing, deferring or declining opportunities based on enterprise priorities and the TA Strategy.
Ce que l’entreprise offre
- CSL’s evaluation standards and prioritization frameworks to ensure rigor, consistency and balanced risk-benefit assessment.
Processus de candidature
- Cross-Functional Partnership and Collaboration:
- Develop and maintain key external partnerships with potential partners in close collaboration with R&D Search.
- Partner with BD Transactions to shape valuation logic, risk scenarios, deal structures and diligence readiness for advanced opportunities.
- Engage with global cross-functional partners including Commercial, Medical, Clinical Development, Regulatory, Technical Operations, Strategy, Finance to inform integrated and robust evaluation outputs.
- Governance and Decision Support:
- Prepare high-quality evaluation summaries, strategic assessments and decision papers for enterprise governance (e.g.
- PRISM, REDC) and other senior bodies as needed (e.g. PDCa, IDC)
- Ensure evaluation outputs reflect analytical depth, strategic clarity, scientific credibility and integrated cross-functional perspectives.
Entreprise et contexte
- Strengthen organizational capability in scientific evaluation, market analysis, disease modelling and structured diligence within the BD function. JOB SPECIFICATIONS Education
- Bachelor’s degree in Life Sciences, Medicine, Pharmacy, Biology, Physiology or a related discipline (required) ;
- Advanced degree such as PhD, MD, PharmD, MSc, MBA, or equivalent scientific/commercial qualification ( strongly preferred) . Experience
- 5-10+ years in pharmaceutical/biotech with substantive exposure to Search & Evaluation, early ‑ stage BD, R&D strategy or new product planning
- Proven ability to assess scientific/commercial potential and influence governance decisions
- Demonstrated success evaluating external opportunities, leading negotiations and influencing cross-functional and senior-level decisions
- Experience partnering across R&D, Commercial, Finance, Regulatory, and Transactions in a global matrix
- Proven ability supporting investment cases and contribute meaningfully to diligence and strategic evaluations Competencies
- Strong scientific literacy across modalities and early development (discovery/preclinical through Phase I) High analytical capab
Détails supplémentaires
- Responsibilities & Accountabilities External Innovation Evaluation Leadership:
- Apply CSL’s evaluation standards and prioritization frameworks to ensure rigor, consistency and balanced risk-benefit assessment.
- PRISM, REDC) and other senior bodies as needed (e.g.
- Support enterprise capital allocation and portfolio shaping discussions with clear strategic logic and evidence-driven recommendations. Team Leadership & Capability Development
- Strengthen organizational capability in scientific evaluation, market analysis, disease modelling and structured diligence within the BD function. JOB SPECIFICATIONS
- Advanced degree such as PhD, MD, PharmD, MSc, MBA, or equivalent scientific/commercial qualification ( strongly preferred) .
- Proven ability supporting investment cases and contribute meaningfully to diligence and strategic evaluations
- Strong scientific literacy across modalities and early development (discovery/preclinical through Phase I) High analytical capab
Notes et contenu original
- Responsibilities & Accountabilities
- External Innovation Evaluation Leadership:
- Support enterprise capital allocation and portfolio shaping discussions with clear strategic logic and evidence-driven recommendations.
- Team Leadership & Capability Development
- Strengthen organizational capability in scientific evaluation, market analysis, disease modelling and structured diligence within the BD function.
- JOB SPECIFICATIONS
- Experience
- Competencies
- Strong scientific literacy across modalities and early development (discovery/preclinical through Phase I)
- High analytical capab
Questions sur cette offre
Quel salaire propose CSL Behring pour ce poste ?
CSL Behring indique CHF 57 500 - 87 000 bruts par an pour ce poste à Bern. Il s'agit du salaire publié dans l'annonce d'origine (ou, si l'employeur ne précise pas de montant, d'une estimation réaliste pour le rôle et le secteur) — le calculateur de ce site le convertit en net réel une fois l'impôt frontalier et les cotisations sociales appliqués.
Est-ce un poste à temps plein, et quel type de contrat propose CSL Behring ?
Cette offre est un poste en temps plein. Le type de contrat affiché ici provient directement de l'annonce originale de l'employeur ; confirmez toujours les horaires exacts, le préavis et la durée d'essai avec CSL Behring pendant le processus de candidature, ces détails pouvant varier même au sein de la même catégorie de contrat.
Ai-je besoin d'un permis de frontalier pour un poste dans le canton de Berne ?
Les résidents UE/AELE domiciliés dans la zone frontalière du pays voisin du canton de Berne peuvent demander un permis G ; l'employeur suisse le dépose auprès de l'office cantonal des migrations après signature du contrat. Les règles de zone frontalière et les délais varient selon le pays voisin et le canton — confirmez les détails auprès de l'office des migrations du canton de Berne ou avec les RH pendant la candidature.
Comment postuler à ce poste chez CSL Behring ?
Utilisez le bouton « Postuler maintenant » sur cette page — il renvoie directement à l'annonce originale de CSL Behring sur csl.wd1.myworkdayjobs.com, votre candidature arrive donc directement dans le système de suivi des candidatures de l'employeur. Frontaliere Ticino ne collecte ni ne transmet lui-même les candidatures.
